SCHEMBL12009729

SCHEMBL12009729

Cc1ccc(N2C(=O)SC(=Cc3cc(C)n(-c4ccccc4F)c3C)C2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR4 O95977 10/20 0.60
▸ NPC1 O15118 6/20 0.60
▸ RAB9A P51151 6/20 0.60
▸ S1PR1 P21453 5/20 0.60
▸ S1PR5 Q9H228 4/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ HTT P42858 3/20 0.60
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ MAPT P10636 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ TCF4 P15884 1/20 0.59
▸ CTNNB1 P35222 1/20 0.59
▸ HDAC6 Q9UBN7 1/20 0.59
▸ TP53 P04637 1/20 0.54
▸ KMT2A Q03164 4/20 0.53
▸ MEN1 O00255 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12009085 0.94 TCF4 (0.67) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL12009028 0.92 S1PR4 (0.58) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL18545612 0.87 TCF4 (0.73) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL12009073 0.87 TCF4 (0.73) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL12009715 0.86 TCF4 (0.65) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL12009730 0.85 TCF4 (0.56) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL18545578 0.84 TCF4 (0.66) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL12009037 0.84 TCF4 (0.66) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL18545581 0.84 TCF4 (0.61) S1PR4NPC1RAB9AS1PR1S1PR5
SCHEMBL13464591 0.84 TCF4 (0.61) S1PR4NPC1RAB9AS1PR1S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 S1PR4 3613/4885NPC1 1604/4885RAB9A 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback